Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hepatitis

  Free Subscription


Articles published in Gastroenterol Hepatol

Retrieve available abstracts of 37 articles:
HTML format



Single Articles


    June 2022
  1. RONCERO C, Buch B, Martin-Sanchez AM, Alvarez-Navares AI, et al
    Prevalence of hepatitis C virus infection in patients with chronic mental disorders: the relevance of dual diagnosis.
    Gastroenterol Hepatol. 2022 Jun 30. pii: S0210-5705(22)00172.
    PubMed     Abstract available


  2. GUTIERREZ-ROJAS L, de la Gandara Martin JJ, Garcia Buey L, Uriz Otano JI, et al
    Patients with severe mental illness and hepatitis C virus infection benefit from new pangenotypic direct-acting antivirals: results of a literature review.
    Gastroenterol Hepatol. 2022 Jun 16. pii: S0210-5705(22)00164.
    PubMed     Abstract available


    May 2022
  3. ANDRES L, Badia E, Fernandez C, Puebla A, et al
    AUTOIMMUNE HEPATITIS. ANOTHER CONSEQUENCE OF COVID-19?
    Gastroenterol Hepatol. 2022 May 13. pii: S0210-5705(22)00150.
    PubMed    


  4. CHEN M, Wu Z, Du Z, Sun S, et al
    Diagnostic accuracy of red blood cell distribution width to platelet ratio for predicting liver fibrosis in patients with chronic hepatitis B: A meta-analysis.
    Gastroenterol Hepatol. 2022;45:361-372.
    PubMed     Abstract available


    April 2022
  5. TORRENTE S, Castiella A, Garmendia M, Zapata E, et al
    Probable autoimmune hepatitis reactivated after COVID-19 vaccination.
    Gastroenterol Hepatol. 2022;45 Suppl 1:115-116.
    PubMed    


  6. MACIA-RODRIGUEZ C, Santome Couto L, Fernandez Villaverde A, Romero Reinoso C, et al
    Mycophenolate mofetil as a treatment of severe steroid-resistant immune-related hepatitis.
    Gastroenterol Hepatol. 2022;45 Suppl 1:32-36.
    PubMed    


    March 2022
  7. NUNEZ F P, Quera R, Bay C, Thomson P, et al
    Fecal microbiota transplant, its usefulness beyond Clostridioides difficile in gastrointestinal diseases.
    Gastroenterol Hepatol. 2022;45:223-230.
    PubMed     Abstract available


  8. PEREZ JIMENEZ RD, Granados Monzon R, Hernandez Febles M, Pena Lopez MJ, et al
    Acute hepatitis due to the hepatitisC virus: Where are the transmission occurring?
    Gastroenterol Hepatol. 2022;45:192-197.
    PubMed     Abstract available


    February 2022
  9. ARANDA EB, Marcos CF, Maestu AP, Marin VG, et al
    EVOLUTION OF HEPATITIS C PATIENTS WITH ADVANCED FIBROSIS OR CIRRHOSIS CURED WITH DIRECT-ACTING ANTIVIRALS. LONG-TERM FOLLOW-UP.
    Gastroenterol Hepatol. 2022 Feb 18. pii: S0210-5705(22)00064.
    PubMed     Abstract available


  10. RASHIDI A, Sedaghat F, Nejat A, Azarpira N, et al
    Immunity to hepatitis A virus in liver transplant recipients: A population-based study in Iran.
    Gastroenterol Hepatol. 2022;45:99-105.
    PubMed     Abstract available


  11. ROCHA HC, Vilela EG
    Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Gastroenterol Hepatol. 2022;45:83-90.
    PubMed     Abstract available


    December 2021
  12. OLIVAS I, Cobreros M, Londono MC, Diaz-Gonzalez A, et al
    Budesonide in the first line treatment of patients with autoimmune hepatitis.
    Gastroenterol Hepatol. 2021 Dec 16. pii: S0210-5705(21)00319.
    PubMed     Abstract available


    October 2021
  13. CALVET X, Carpio D, Rodriguez-Lago I, Garcia-Vicuna R, et al
    Risk of infection associated with Janus Kinase (JAK) inhibitors and biological therapies in inflammatory intestinal disease and rheumatoid arthritis. Prevention strategies.
    Gastroenterol Hepatol. 2021;44:587-598.
    PubMed     Abstract available


    September 2021
  14. GARCIA-FRAILE LJ, Garcia-Buey L, Cerezo CA, Sanz JS, et al
    ENGLISH: Evolution of HCV associated Porphyria Cutanea Tarda after HCV Sustained Virologic Response by Direct Acting Antivirals.
    Gastroenterol Hepatol. 2021 Sep 22. pii: S0210-5705(21)00248.
    PubMed     Abstract available


  15. DE CANETE CAMACHO JCF, Martinez AM, Mena MAG, Maria Moreno Planas J, et al
    Influence of psychiatric disorders and opioid substitution therapy on hepatitis c treatment with direct-acting antivirals in people who inject drugs.
    Gastroenterol Hepatol. 2021 Sep 17. pii: S0210-5705(21)00251.
    PubMed     Abstract available


  16. CAMARERO JG, Aranda EB, Castro RQ, Chumillas RMS, et al
    Hepatitis B And C Screening In Hospitalized Patients With Sars-Cov-2 Infection.
    Gastroenterol Hepatol. 2021 Sep 8. pii: S0210-5705(21)00250.
    PubMed     Abstract available


    June 2021
  17. TURNES J, Rincon D, Calleja JL, Delgado MB, et al
    Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naive non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study.
    Gastroenterol Hepatol. 2021 Jun 12. pii: S0210-5705(21)00198.
    PubMed     Abstract available


    May 2021
  18. REYGOSA C, Arraez DM, Hernandez-Bustabad A, Baute LM, et al
    Hepatitis C-Treated Patients As A Potential Source For Referral Of New Cases.
    Gastroenterol Hepatol. 2021 May 20. pii: S0210-5705(21)00148.
    PubMed     Abstract available


    April 2021
  19. BUSTA NISTAL MR, Garcia Sanchez MC, Mora Cuadrado N, Dura Gil M, et al
    Cholestatic hepatitis as a presentation of secondary syphilis.
    Gastroenterol Hepatol. 2021 Apr 16. pii: S0210-5705(21)00117.
    PubMed    


  20. COSTA CA, Garcia JLR, Gandia MAR, Martos RF, et al
    FULMINANT LIVER FAILURE DUE TO HEPATITIS B REACTIVATION DURING THE COVID-19 PANDEMIC.
    Gastroenterol Hepatol. 2021 Apr 13. pii: S0210-5705(21)00118.
    PubMed    


    November 2020
  21. ABIA PL, Sabater AM, Delgado SM, Haym MCB, et al
    Heat stroke and fulminant hepatitis: conservative management or liver transplant?
    Gastroenterol Hepatol. 2020 Nov 27. pii: S0210-5705(20)30435.
    PubMed    


  22. BARTRES C, Soy G, Forns X
    Hepatitis C therapy and anticonvulsants.
    Gastroenterol Hepatol. 2020 Nov 27. pii: S0210-5705(20)30432.
    PubMed    


  23. CRESPO J
    Screening guide for HCV infection in Spain.
    Gastroenterol Hepatol. 2020 Nov 19. pii: S0210-5705(20)30430.
    PubMed    


  24. GUTIERREZ GARCIA ML, Gomez Perosanz R, Acedo Sanz JM, Delgado-Iribarren Garcia-Campero A, et al
    Coordinated assistance plan for the elimination of hepatitis C virus at the centro de ayuda integral al drogodependiente (CAID (Comprehensive Care Centre for Drug Addicts)).
    Gastroenterol Hepatol. 2020 Nov 5. pii: S0210-5705(20)30315.
    PubMed     Abstract available


    October 2020
  25. MUNOZ-CODOCEO C, Amo M, Martin A, Martin-Arriscado Arroba C, et al
    Diagnostic accuracy of liver and spleen stiffness measured by fibroscan(R) in the prediction of esophageal varices in HCV-related cirrhosis patients treated with oral antivirals.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30321.
    PubMed     Abstract available


  26. YOZGAT A, Can G, Can H, Ekmen N, et al
    Social stigmatization in Turkish patients with chronic hepatitis B and C.
    Gastroenterol Hepatol. 2020 Oct 20. pii: S0210-5705(20)30366.
    PubMed     Abstract available


  27. LAGUNO CENTENO M, Alvarez B, Martinez-Rebollar M, de la Mora L, et al
    Efficacy of Elbasvir/Grazoprevir in Early Chronic G1/G4 Hepatitis C infection in HIV/HCV co-infected patients with mild fibrosis.
    Gastroenterol Hepatol. 2020 Oct 8. pii: S0210-5705(20)30280.
    PubMed     Abstract available


  28. TELLEZ L, Martin Mateos RM
    COVID-19 and liver disease: An update.
    Gastroenterol Hepatol. 2020;43:472-480.
    PubMed     Abstract available


    September 2020
  29. YANG Q, Zhong Z, Yang Y, Ma Y, et al
    Efficacy and Safety of Tenofovir in the Prevention of Perinatal Transmission of Hepatitis B, a Meta-Analysis.
    Gastroenterol Hepatol. 2020 Sep 15. pii: S0210-5705(20)30226.
    PubMed     Abstract available


  30. ZHANG ZQ, Shi BS, Lu W, Liu DP, et al
    Quantitative HBcrAg and HBcAb versus HBsAg and HBV DNA in predicting liver fibrosis levels of chronic hepatitis B patients.
    Gastroenterol Hepatol. 2020 Sep 10. pii: S0210-5705(20)30231.
    PubMed     Abstract available


    August 2020
  31. RODRIGUEZ M, Buti M, Esteban R, Lens S, et al
    Consensus document of the Spanish Association for Study of the Liver on the treatment of hepatitis B virus infection (2020).
    Gastroenterol Hepatol. 2020 Aug 7. pii: S0210-5705(20)30158.
    PubMed     Abstract available


    July 2020
  32. RIADO MINGUEZ D, Gutierrez Garcia ML, Fernandez Rodriguez C
    Chronic autoimmune hepatitis triggered by olmesartan.
    Gastroenterol Hepatol. 2020 Jul 13. pii: S0210-5705(20)30232.
    PubMed    


    June 2020
  33. RODRIGUEZ-GANDIA MA, Lopez-Hervas P, Tellez L, Gajate L, et al
    Successful urgent liver transplant due to fulminant autoimmune hepatitis during the height of the COVID-19 pandemic in Spain.
    Gastroenterol Hepatol. 2020 Jun 11. pii: S0210-5705(20)30213.
    PubMed    


    April 2020
  34. GUZMAN RAMOS MI, Manzano-Garcia M, Robustillo-Cortes MLA, Pineda JA, et al
    Effect on the adherence to concomitant medications after initiation of treatment with direct-acting antiviral agents against hepatitis C virus.
    Gastroenterol Hepatol. 2020 Apr 9. pii: S0210-5705(20)30071.
    PubMed     Abstract available


    March 2020
  35. MAS ORDEIG A, Bordon Garcia N
    Hepatotoxicity caused by Garcinia cambogia.
    Gastroenterol Hepatol. 2020;43:134-135.
    PubMed    


    February 2020
  36. FERNANDEZ I, Pascasio JM, Colmenero J
    Prophylaxis and treatment in liver transplantation. VII Consensus Document of the Spanish Society of Liver Transplantation.
    Gastroenterol Hepatol. 2020 Feb 21. pii: S0210-5705(20)30015.
    PubMed     Abstract available


    September 2019
  37. LLOVET LP, Sciarrone S, Rodriguez-Tajes S, Montironi C, et al
    Ductular reaction and hepatocyte ballooning identify patients with fibrosing cholestatic hepatitits after liver transplantation.
    Gastroenterol Hepatol. 2019 Sep 5. pii: S0210-5705(19)30173.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: